Grégoire Desrousseaux

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Recommended - Individuals

Gold - Individuals: litigation

Recommended - Individuals: transactions

Though it is best known as one of France’s premier patent litigation outfits, August Debouzy has a growing prosecution unit too, meaning it can now serve patrons’ needs from cradle to grave. “The team carefully and precisely prepare for hearings, running mock trials internally. They always keep clients updated about the case, proceedings and the tactics of the other side.” The firm rules the roost on both the high-technology and pharmaceutical sides, with the past year seeing it act on a series of cases for Huawei – which include FRAND and SEP components – and a set of actions for Teva against Merck Sharp & Dohme, Novartis and Sanofi. Acting on the former is Grégoire Desrousseaux, while the latter has been handled by François Pochart. The technically capable Desrousseaux benefits from having spent time as a patent attorney prior to being admitted to the Paris Bar, and now puts his skills to use as one of the biggest names in French telecommunications and FRAND litigation. “Clients appreciate Grégoire’s excellent and to-the-point strategic advice. He fully satisfies and even overmatches their demands, immediately making himself available and quickly forming an opinion. He has great expertise when it comes to both intellectual property and general contractual matters too.” Pochart, who has been a patent attorney for more than 15 years, also has scientific capability. He acts in some of the most high-profile life sciences patent litigation happening in France, and also brings valuable knowledge of regulatory issues in the pharmaceutical and medical devices spheres.

Get unlimited access to all IAM content